Abstract
A man with acute lymphoblastic leukaemia developed disseminated Scedosporium prolificans infection following chemotherapy for disease relapse while on posaconazole prophylaxis. Scedosporium prolificans infection during posaconazole prophylaxis has not been reported previously. This report is timely as the uptake of posaconazole, the broadest spectrum azole clinically available, is likely to grow with recent evidence supporting its role as prophylaxis against invasive fungal infections in high-risk haematology patients.
| Original language | English |
|---|---|
| Pages (from-to) | 83-86 |
| Number of pages | 4 |
| Journal | Mycopathologia |
| Volume | 166 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 1 Aug 2008 |
| Externally published | Yes |
Keywords
- Acute leukaemia
- Posaconazole
- Scedosporium prolificans
Cite this
}
Breakthrough disseminated Scedosporium prolificans infection in a patient with relapsed leukaemia on prolonged voriconazole followed by posaconazole prophylaxis. / Ananda-Rajah, M. R.; Grigg, A.; Slavin, M. A.
In: Mycopathologia, Vol. 166, No. 2, 01.08.2008, p. 83-86.Research output: Contribution to journal › Article › Research › peer-review
TY - JOUR
T1 - Breakthrough disseminated Scedosporium prolificans infection in a patient with relapsed leukaemia on prolonged voriconazole followed by posaconazole prophylaxis
AU - Ananda-Rajah, M. R.
AU - Grigg, A.
AU - Slavin, M. A.
PY - 2008/8/1
Y1 - 2008/8/1
N2 - A man with acute lymphoblastic leukaemia developed disseminated Scedosporium prolificans infection following chemotherapy for disease relapse while on posaconazole prophylaxis. Scedosporium prolificans infection during posaconazole prophylaxis has not been reported previously. This report is timely as the uptake of posaconazole, the broadest spectrum azole clinically available, is likely to grow with recent evidence supporting its role as prophylaxis against invasive fungal infections in high-risk haematology patients.
AB - A man with acute lymphoblastic leukaemia developed disseminated Scedosporium prolificans infection following chemotherapy for disease relapse while on posaconazole prophylaxis. Scedosporium prolificans infection during posaconazole prophylaxis has not been reported previously. This report is timely as the uptake of posaconazole, the broadest spectrum azole clinically available, is likely to grow with recent evidence supporting its role as prophylaxis against invasive fungal infections in high-risk haematology patients.
KW - Acute leukaemia
KW - Posaconazole
KW - Scedosporium prolificans
UR - http://www.scopus.com/inward/record.url?scp=46949103068&partnerID=8YFLogxK
U2 - 10.1007/s11046-008-9131-2
DO - 10.1007/s11046-008-9131-2
M3 - Article
C2 - 18512130
AN - SCOPUS:46949103068
VL - 166
SP - 83
EP - 86
JO - Mycopathologia
JF - Mycopathologia
SN - 0301-486X
IS - 2
ER -